[Eating act and people with Down Syndrome].

This is en experience report lived in the Health and Nursing Assistance Projects of the Post-Graduate Nursing Master Degree of the Federal University of Santa Catarina as an interdisciplinary subject, and it was done with Down's Syndrome people, concentrating in their rationality and imaginary. We tried to build with these people and their families an individualized nutritional systematization that contributes to their personal independence in the daily practice of the act of eating. The postulates of symbolic interactionism guided this practice and established a connection with the methodological instruments of sensible listening and observation, besides playful activities.

[Ayurveda diet and the nursing consultation: a care proposal].

The present text is based on the final paper on a subject from the graduate program of the Federal University of Santa Catarina. In this paper, I propose the implementation of nursing consultations providing ayurvedic dietary advice as part of the services offered in Primary Care Units for assisting patients with diabetes mellitus and high blood pressure. For a better understanding, I bring a brief revision on both ayurveda medicine and diet, emphasizing the importance of balance and harmony of the doshas for maintaining or reaching a good quality of living.

DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats.

This study examined the effects of DAU 6215, a selective 5-HT3-receptor antagonist, on either impairment of a passive-avoidance task or hypermotility, both caused by scopolamine in rats. In the first experiment, scopolamine (0.75 mg kg-1, i.

Effect of mifentidine on mepirizole-induced duodenal ulcer in the rat.

The H2-receptor antagonists mifentidine, famotidine, cimetidine and ranitidine were examined for their ability to prevent the duodenal ulcer caused by mepirizole (250 mg/kg p.o.), a non-steroidal anti-inflammatory agent, in the conscious rat.

WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.

Single intravenous administration of platelet activating factor (PAF; 4 micrograms/kg) induced reproducible gastric damage in the conscious rat which was prevented by WEB 2086, a potent and specific PAF-antagonist. Intravenous and oral ED50s in protecting rats from gastric damage were 61 and 633 micrograms/kg, respectively. Because of the reported association between septic shock and gastrointestinal ulceration, the therapeutic potential of PAF-antagonists might be broader than previously thought.